Benefit-risk analysis for the clinician: 'primum non nocere' revisited-the case for antipsychotics in the treatment of behavioural disturbances in dementia

P. Naarding, M. van Grevenstein, A.T.F. Beekman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)437-440
JournalInternational Journal of Geriatric Psychiatry
Volume25
Issue number5
DOIs
Publication statusPublished - 2010

Cite this